#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Discussion
2-1	4-14	Discussion	abstract	new	_	_

#Text=Naturally , as the VAD and the controller are implanted in humans , because their lifespan depends largely on the suitability of the pump control , we must have great certainty in the robustness of the control algorithms .
3-1	15-24	Naturally	_	_	_	_
3-2	25-26	,	_	_	_	_
3-3	27-29	as	_	_	_	_
3-4	30-33	the	abstract[3]	new[3]	_	_
3-5	34-37	VAD	abstract[3]	new[3]	_	_
3-6	38-41	and	_	_	_	_
3-7	42-45	the	object[4]	new[4]	coref	10-11[70_4]
3-8	46-56	controller	object[4]	new[4]	_	_
3-9	57-60	are	_	_	_	_
3-10	61-70	implanted	_	_	_	_
3-11	71-73	in	_	_	_	_
3-12	74-80	humans	person	new	ana	3-15
3-13	81-82	,	_	_	_	_
3-14	83-90	because	_	_	_	_
3-15	91-96	their	person|abstract[7]	giv|new[7]	_	_
3-16	97-105	lifespan	abstract[7]	new[7]	_	_
3-17	106-113	depends	_	_	_	_
3-18	114-121	largely	_	_	_	_
3-19	122-124	on	_	_	_	_
3-20	125-128	the	abstract[8]	new[8]	_	_
3-21	129-140	suitability	abstract[8]	new[8]	_	_
3-22	141-143	of	abstract[8]	new[8]	_	_
3-23	144-147	the	abstract[8]|event[10]	new[8]|new[10]	coref	3-37[0_10]
3-24	148-152	pump	abstract[8]|object|event[10]	new[8]|new|new[10]	coref	9-1[62_0]
3-25	153-160	control	abstract[8]|event[10]	new[8]|new[10]	_	_
3-26	161-162	,	_	_	_	_
3-27	163-165	we	person	acc	ana	8-1
3-28	166-170	must	_	_	_	_
3-29	171-175	have	_	_	_	_
3-30	176-181	great	abstract[12]	new[12]	_	_
3-31	182-191	certainty	abstract[12]	new[12]	_	_
3-32	192-194	in	abstract[12]	new[12]	_	_
3-33	195-198	the	abstract[12]|abstract[13]	new[12]|new[13]	_	_
3-34	199-209	robustness	abstract[12]|abstract[13]	new[12]|new[13]	_	_
3-35	210-212	of	abstract[12]|abstract[13]	new[12]|new[13]	_	_
3-36	213-216	the	abstract[12]|abstract[13]|abstract[15]	new[12]|new[13]|new[15]	_	_
3-37	217-224	control	abstract[12]|abstract[13]|event|abstract[15]	new[12]|new[13]|giv|new[15]	coref	5-7[31_0]
3-38	225-235	algorithms	abstract[12]|abstract[13]|abstract[15]	new[12]|new[13]|new[15]	_	_
3-39	236-237	.	_	_	_	_

#Text=Continuous flow for VADs may allow simulated pulses ; however , until the date of circulatory assistance , despite tolerance to left ventricular and Pao , the continuous flow rate is traditionally of a medium constant rotation , which always decreases the pressure pulse .
4-1	238-248	Continuous	abstract[16]	new[16]	coref	4-29[0_16]
4-2	249-253	flow	abstract[16]	new[16]	_	_
4-3	254-257	for	abstract[16]	new[16]	_	_
4-4	258-262	VADs	abstract[16]|abstract	new[16]|new	_	_
4-5	263-266	may	_	_	_	_
4-6	267-272	allow	_	_	_	_
4-7	273-282	simulated	abstract[18]	new[18]	_	_
4-8	283-289	pulses	abstract[18]	new[18]	_	_
4-9	290-291	;	_	_	_	_
4-10	292-299	however	time[19]	new[19]	_	_
4-11	300-301	,	time[19]	new[19]	_	_
4-12	302-307	until	time[19]	new[19]	_	_
4-13	308-311	the	time[19]	new[19]	_	_
4-14	312-316	date	time[19]	new[19]	_	_
4-15	317-319	of	time[19]	new[19]	_	_
4-16	320-331	circulatory	time[19]|place|event[21]	new[19]|new|new[21]	_	_
4-17	332-342	assistance	time[19]|event[21]	new[19]|new[21]	_	_
4-18	343-344	,	time[19]	new[19]	_	_
4-19	345-352	despite	time[19]	new[19]	_	_
4-20	353-362	tolerance	time[19]|abstract	new[19]|new	_	_
4-21	363-365	to	_	_	_	_
4-22	366-370	left	_	_	_	_
4-23	371-382	ventricular	abstract	new	_	_
4-24	383-386	and	_	_	_	_
4-25	387-390	Pao	object	new	_	_
4-26	391-392	,	_	_	_	_
4-27	393-396	the	abstract[26]	new[26]	coref	11-13[83_26]
4-28	397-407	continuous	abstract[26]	new[26]	_	_
4-29	408-412	flow	abstract|abstract[26]	giv|new[26]	coref	5-16
4-30	413-417	rate	abstract[26]	new[26]	_	_
4-31	418-420	is	_	_	_	_
4-32	421-434	traditionally	abstract[27]	new[27]	_	_
4-33	435-437	of	abstract[27]	new[27]	_	_
4-34	438-439	a	abstract[27]	new[27]	_	_
4-35	440-446	medium	abstract[27]	new[27]	_	_
4-36	447-455	constant	abstract[27]	new[27]	_	_
4-37	456-464	rotation	abstract[27]	new[27]	_	_
4-38	465-466	,	_	_	_	_
4-39	467-472	which	_	_	_	_
4-40	473-479	always	_	_	_	_
4-41	480-489	decreases	_	_	_	_
4-42	490-493	the	event[29]	new[29]	_	_
4-43	494-502	pressure	abstract|event[29]	new|new[29]	coref	5-18
4-44	503-508	pulse	event[29]	new[29]	_	_
4-45	509-510	.	_	_	_	_

#Text=These types of devices generally require precise control and the use of sensors to measure flow and pressure .
5-1	511-516	These	object[30]	new[30]	coref	6-1[36_30]
5-2	517-522	types	object[30]	new[30]	_	_
5-3	523-525	of	object[30]	new[30]	_	_
5-4	526-533	devices	object[30]	new[30]	_	_
5-5	534-543	generally	_	_	_	_
5-6	544-551	require	_	_	_	_
5-7	552-559	precise	event[31]	giv[31]	coref	11-3[0_31]
5-8	560-567	control	event[31]	giv[31]	_	_
5-9	568-571	and	_	_	_	_
5-10	572-575	the	abstract[32]	new[32]	_	_
5-11	576-579	use	abstract[32]	new[32]	_	_
5-12	580-582	of	abstract[32]	new[32]	_	_
5-13	583-590	sensors	abstract[32]|object	new[32]|new	coref	7-7[44_0]
5-14	591-593	to	_	_	_	_
5-15	594-601	measure	_	_	_	_
5-16	602-606	flow	abstract	giv	coref	9-3
5-17	607-610	and	_	_	_	_
5-18	611-619	pressure	abstract	giv	coref	9-15
5-19	620-621	.	_	_	_	_

#Text=These devices are not reliable , owing to clinical issues such as routine calibration and blood clotting .
6-1	622-627	These	object[36]	giv[36]	_	_
6-2	628-635	devices	object[36]	giv[36]	_	_
6-3	636-639	are	_	_	_	_
6-4	640-643	not	_	_	_	_
6-5	644-652	reliable	_	_	_	_
6-6	653-654	,	_	_	_	_
6-7	655-660	owing	_	_	_	_
6-8	661-663	to	_	_	_	_
6-9	664-672	clinical	abstract[37]	new[37]	_	_
6-10	673-679	issues	abstract[37]	new[37]	_	_
6-11	680-684	such	abstract[37]	new[37]	_	_
6-12	685-687	as	abstract[37]	new[37]	_	_
6-13	688-695	routine	abstract[37]|abstract[38]	new[37]|new[38]	_	_
6-14	696-707	calibration	abstract[37]|abstract[38]	new[37]|new[38]	_	_
6-15	708-711	and	abstract[37]	new[37]	_	_
6-16	712-717	blood	abstract[37]|substance|abstract[40]	new[37]|new|new[40]	_	_
6-17	718-726	clotting	abstract[37]|abstract[40]	new[37]|new[40]	_	_
6-18	727-728	.	_	_	_	_

#Text=These concerns regarding the reliability of implantable sensors have led to the search for non-invasive , sensorless approaches to identifying analog cardiac preload .
7-1	729-734	These	abstract[41]	new[41]	_	_
7-2	735-743	concerns	abstract[41]	new[41]	_	_
7-3	744-753	regarding	_	_	_	_
7-4	754-757	the	abstract[42]	new[42]	_	_
7-5	758-769	reliability	abstract[42]	new[42]	_	_
7-6	770-772	of	abstract[42]	new[42]	_	_
7-7	773-784	implantable	abstract[42]|object|object[44]	new[42]|new|giv[44]	_	_
7-8	785-792	sensors	abstract[42]|object[44]	new[42]|giv[44]	_	_
7-9	793-797	have	_	_	_	_
7-10	798-801	led	_	_	_	_
7-11	802-804	to	_	_	_	_
7-12	805-808	the	abstract[45]	new[45]	_	_
7-13	809-815	search	abstract[45]	new[45]	_	_
7-14	816-819	for	abstract[45]	new[45]	_	_
7-15	820-832	non-invasive	abstract[45]|abstract[47]	new[45]|new[47]	coref	14-22[0_47]
7-16	833-834	,	abstract[45]|abstract[47]	new[45]|new[47]	_	_
7-17	835-845	sensorless	abstract[45]|abstract|abstract[47]	new[45]|new|new[47]	coref	8-23
7-18	846-856	approaches	abstract[45]|abstract[47]	new[45]|new[47]	_	_
7-19	857-859	to	_	_	_	_
7-20	860-871	identifying	_	_	_	_
7-21	872-878	analog	abstract[49]	new[49]	coref	13-11[0_49]
7-22	879-886	cardiac	person|abstract[49]	new|new[49]	_	_
7-23	887-894	preload	abstract[49]	new[49]	_	_
7-24	895-896	.	_	_	_	_

#Text=We now believe that non-invasive technology has advanced to a level where it can be considered for long-term implantation , combined with sensorless signals , to form a robust control system that provides physiological behavior to RBPs .
8-1	897-899	We	person	giv	ana	10-26
8-2	900-903	now	_	_	_	_
8-3	904-911	believe	_	_	_	_
8-4	912-916	that	_	_	_	_
8-5	917-929	non-invasive	abstract[51]	new[51]	_	_
8-6	930-940	technology	abstract[51]	new[51]	_	_
8-7	941-944	has	_	_	_	_
8-8	945-953	advanced	_	_	_	_
8-9	954-956	to	_	_	_	_
8-10	957-958	a	abstract[52]	new[52]	ana	8-13[0_52]
8-11	959-964	level	abstract[52]	new[52]	_	_
8-12	965-970	where	_	_	_	_
8-13	971-973	it	abstract	giv	_	_
8-14	974-977	can	_	_	_	_
8-15	978-980	be	_	_	_	_
8-16	981-991	considered	_	_	_	_
8-17	992-995	for	_	_	_	_
8-18	996-1005	long-term	event[54]	new[54]	_	_
8-19	1006-1018	implantation	event[54]	new[54]	_	_
8-20	1019-1020	,	_	_	_	_
8-21	1021-1029	combined	_	_	_	_
8-22	1030-1034	with	_	_	_	_
8-23	1035-1045	sensorless	abstract|abstract[56]	giv|new[56]	coref|coref	14-19|14-19
8-24	1046-1053	signals	abstract[56]	new[56]	_	_
8-25	1054-1055	,	_	_	_	_
8-26	1056-1058	to	_	_	_	_
8-27	1059-1063	form	_	_	_	_
8-28	1064-1065	a	abstract[58]	new[58]	_	_
8-29	1066-1072	robust	abstract[58]	new[58]	_	_
8-30	1073-1080	control	person|abstract[58]	new|new[58]	_	_
8-31	1081-1087	system	abstract[58]	new[58]	_	_
8-32	1088-1092	that	_	_	_	_
8-33	1093-1101	provides	_	_	_	_
8-34	1102-1115	physiological	abstract[59]	new[59]	_	_
8-35	1116-1124	behavior	abstract[59]	new[59]	_	_
8-36	1125-1127	to	_	_	_	_
8-37	1128-1132	RBPs	abstract	new	_	_
8-38	1133-1134	.	_	_	_	_

#Text=The pulsatile flow pump is used as a non-invasive substitute for the LV filling pressure , as it has been proven to be closely interrelated .
9-1	1135-1138	The	object[62]	giv[62]	coref	10-1[66_62]
9-2	1139-1148	pulsatile	object[62]	giv[62]	_	_
9-3	1149-1153	flow	abstract|object[62]	giv|giv[62]	coref	10-7
9-4	1154-1158	pump	object[62]	giv[62]	_	_
9-5	1159-1161	is	_	_	_	_
9-6	1162-1166	used	_	_	_	_
9-7	1167-1169	as	_	_	_	_
9-8	1170-1171	a	_	_	_	_
9-9	1172-1184	non-invasive	_	_	_	_
9-10	1185-1195	substitute	_	_	_	_
9-11	1196-1199	for	_	_	_	_
9-12	1200-1203	the	substance[63]	new[63]	_	_
9-13	1204-1206	LV	substance[63]	new[63]	_	_
9-14	1207-1214	filling	_	_	_	_
9-15	1215-1223	pressure	abstract	giv	ana	9-18
9-16	1224-1225	,	_	_	_	_
9-17	1226-1228	as	_	_	_	_
9-18	1229-1231	it	abstract	giv	_	_
9-19	1232-1235	has	_	_	_	_
9-20	1236-1240	been	_	_	_	_
9-21	1241-1247	proven	_	_	_	_
9-22	1248-1250	to	_	_	_	_
9-23	1251-1253	be	_	_	_	_
9-24	1254-1261	closely	_	_	_	_
9-25	1262-1274	interrelated	_	_	_	_
9-26	1275-1276	.	_	_	_	_

#Text=The pump flow pulsation and mean flow pump used in the current controller can be estimated using an algorithm for flow estimation previously established in our laboratory using the pump speed and current that are not measured invasively .
10-1	1277-1280	The	object[66]	giv[66]	coref	10-7[69_66]
10-2	1281-1285	pump	object[66]	giv[66]	_	_
10-3	1286-1290	flow	_	_	_	_
10-4	1291-1300	pulsation	abstract	new	_	_
10-5	1301-1304	and	_	_	_	_
10-6	1305-1309	mean	_	_	_	_
10-7	1310-1314	flow	abstract|object[69]	giv|giv[69]	coref|coref|coref|coref	10-21|10-30[0_69]|10-21|10-30[0_69]
10-8	1315-1319	pump	object[69]	giv[69]	_	_
10-9	1320-1324	used	_	_	_	_
10-10	1325-1327	in	_	_	_	_
10-11	1328-1331	the	object[70]	giv[70]	coref	15-8[123_70]
10-12	1332-1339	current	object[70]	giv[70]	_	_
10-13	1340-1350	controller	object[70]	giv[70]	_	_
10-14	1351-1354	can	_	_	_	_
10-15	1355-1357	be	_	_	_	_
10-16	1358-1367	estimated	_	_	_	_
10-17	1368-1373	using	_	_	_	_
10-18	1374-1376	an	abstract[71]	new[71]	_	_
10-19	1377-1386	algorithm	abstract[71]	new[71]	_	_
10-20	1387-1390	for	abstract[71]	new[71]	_	_
10-21	1391-1395	flow	abstract[71]|abstract|abstract[73]	new[71]|giv|new[73]	coref|coref	11-6|11-6
10-22	1396-1406	estimation	abstract[71]|abstract[73]	new[71]|new[73]	_	_
10-23	1407-1417	previously	_	_	_	_
10-24	1418-1429	established	_	_	_	_
10-25	1430-1432	in	_	_	_	_
10-26	1433-1436	our	person|place[75]	giv|new[75]	_	_
10-27	1437-1447	laboratory	place[75]	new[75]	_	_
10-28	1448-1453	using	_	_	_	_
10-29	1454-1457	the	abstract[77]	new[77]	coref	15-23[128_77]
10-30	1458-1462	pump	object|abstract[77]	giv|new[77]	coref	12-19
10-31	1463-1468	speed	abstract[77]	new[77]	_	_
10-32	1469-1472	and	_	_	_	_
10-33	1473-1480	current	_	_	_	_
10-34	1481-1485	that	_	_	_	_
10-35	1486-1489	are	_	_	_	_
10-36	1490-1493	not	_	_	_	_
10-37	1494-1502	measured	_	_	_	_
10-38	1503-1513	invasively	_	_	_	_
10-39	1514-1515	.	_	_	_	_

#Text=The current control approach uses flow pulsatility as a parameter to determine the required flow rate compared to the continuous pulsatility index ( PI ) control strategy , which regulates PI directly at a specific stage .
11-1	1516-1519	The	abstract[79]	new[79]	_	_
11-2	1520-1527	current	abstract[79]	new[79]	_	_
11-3	1528-1535	control	event|abstract[79]	giv|new[79]	coref	11-26
11-4	1536-1544	approach	abstract[79]	new[79]	_	_
11-5	1545-1549	uses	_	_	_	_
11-6	1550-1554	flow	abstract|abstract[81]	giv|new[81]	coref|coref|coref|coref	11-15|11-21[0_81]|11-15|11-21[0_81]
11-7	1555-1566	pulsatility	abstract[81]	new[81]	_	_
11-8	1567-1569	as	_	_	_	_
11-9	1570-1571	a	_	_	_	_
11-10	1572-1581	parameter	_	_	_	_
11-11	1582-1584	to	_	_	_	_
11-12	1585-1594	determine	_	_	_	_
11-13	1595-1598	the	abstract[83]	giv[83]	_	_
11-14	1599-1607	required	abstract[83]	giv[83]	_	_
11-15	1608-1612	flow	abstract|abstract[83]	giv|giv[83]	_	_
11-16	1613-1617	rate	abstract[83]	giv[83]	_	_
11-17	1618-1626	compared	_	_	_	_
11-18	1627-1629	to	_	_	_	_
11-19	1630-1633	the	abstract[85]	new[85]	appos	11-24[0_85]
11-20	1634-1644	continuous	abstract[85]	new[85]	_	_
11-21	1645-1656	pulsatility	abstract|abstract[85]	giv|new[85]	coref	12-15[96_0]
11-22	1657-1662	index	abstract[85]	new[85]	_	_
11-23	1663-1664	(	_	_	_	_
11-24	1665-1667	PI	abstract	giv	coref	11-31
11-25	1668-1669	)	_	_	_	_
11-26	1670-1677	control	event|abstract[88]	giv|new[88]	coref|coref	14-16|14-16
11-27	1678-1686	strategy	abstract[88]	new[88]	_	_
11-28	1687-1688	,	_	_	_	_
11-29	1689-1694	which	_	_	_	_
11-30	1695-1704	regulates	_	_	_	_
11-31	1705-1707	PI	abstract	giv	coref	12-38
11-32	1708-1716	directly	_	_	_	_
11-33	1717-1719	at	_	_	_	_
11-34	1720-1721	a	abstract[90]	new[90]	ana	12-1[0_90]
11-35	1722-1730	specific	abstract[90]	new[90]	_	_
11-36	1731-1736	stage	abstract[90]	new[90]	_	_
11-37	1737-1738	.	_	_	_	_

#Text=This allows the left ventricle to automatically adjust the RV output ( represented by the increased or decreased pump pulsatility ) , thereby decreasing the danger of suction or an inefficient pumping aid connected to improperly defined PI target values .
12-1	1739-1743	This	abstract	giv	_	_
12-2	1744-1750	allows	_	_	_	_
12-3	1751-1754	the	object[92]	new[92]	_	_
12-4	1755-1759	left	object[92]	new[92]	_	_
12-5	1760-1769	ventricle	object[92]	new[92]	_	_
12-6	1770-1772	to	_	_	_	_
12-7	1773-1786	automatically	_	_	_	_
12-8	1787-1793	adjust	_	_	_	_
12-9	1794-1797	the	abstract[94]	new[94]	_	_
12-10	1798-1800	RV	abstract|abstract[94]	new|new[94]	_	_
12-11	1801-1807	output	abstract[94]	new[94]	_	_
12-12	1808-1809	(	_	_	_	_
12-13	1810-1821	represented	_	_	_	_
12-14	1822-1824	by	_	_	_	_
12-15	1825-1828	the	abstract[96]	giv[96]	_	_
12-16	1829-1838	increased	abstract[96]	giv[96]	_	_
12-17	1839-1841	or	abstract[96]	giv[96]	_	_
12-18	1842-1851	decreased	abstract[96]	giv[96]	_	_
12-19	1852-1856	pump	object|abstract[96]	giv|giv[96]	_	_
12-20	1857-1868	pulsatility	abstract[96]	giv[96]	_	_
12-21	1869-1870	)	_	_	_	_
12-22	1871-1872	,	_	_	_	_
12-23	1873-1880	thereby	_	_	_	_
12-24	1881-1891	decreasing	_	_	_	_
12-25	1892-1895	the	abstract[97]	new[97]	_	_
12-26	1896-1902	danger	abstract[97]	new[97]	_	_
12-27	1903-1905	of	abstract[97]	new[97]	_	_
12-28	1906-1913	suction	abstract[97]|event	new[97]|new	_	_
12-29	1914-1916	or	abstract[97]	new[97]	_	_
12-30	1917-1919	an	abstract[97]|abstract[100]	new[97]|new[100]	_	_
12-31	1920-1931	inefficient	abstract[97]|abstract[100]	new[97]|new[100]	_	_
12-32	1932-1939	pumping	abstract[97]|abstract|abstract[100]	new[97]|new|new[100]	_	_
12-33	1940-1943	aid	abstract[97]|abstract[100]	new[97]|new[100]	_	_
12-34	1944-1953	connected	_	_	_	_
12-35	1954-1956	to	_	_	_	_
12-36	1957-1967	improperly	_	_	_	_
12-37	1968-1975	defined	_	_	_	_
12-38	1976-1978	PI	abstract|abstract[103]	giv|new[103]	coref|coref	13-4|13-4
12-39	1979-1985	target	abstract|abstract[103]	new|new[103]	coref	13-3
12-40	1986-1992	values	abstract[103]	new[103]	_	_
12-41	1993-1994	.	_	_	_	_

#Text=The optimal target PI value depends on heart contractility , preload , and afterload .
13-1	1995-1998	The	quantity[106]	new[106]	_	_
13-2	1999-2006	optimal	quantity[106]	new[106]	_	_
13-3	2007-2013	target	abstract|quantity[106]	giv|new[106]	_	_
13-4	2014-2016	PI	abstract|quantity[106]	giv|new[106]	coref	41-9
13-5	2017-2022	value	quantity[106]	new[106]	_	_
13-6	2023-2030	depends	_	_	_	_
13-7	2031-2033	on	_	_	_	_
13-8	2034-2039	heart	abstract|abstract[108]	new|new[108]	coref|coref	32-15[144_108]|32-15[144_108]
13-9	2040-2053	contractility	abstract[108]	new[108]	_	_
13-10	2054-2055	,	_	_	_	_
13-11	2056-2063	preload	abstract	giv	_	_
13-12	2064-2065	,	_	_	_	_
13-13	2066-2069	and	_	_	_	_
13-14	2070-2079	afterload	abstract	new	_	_
13-15	2080-2081	.	_	_	_	_

#Text=The methodology of this work is proposed to evaluate the merits of a full-state feedback control method involving sensorless and non-invasive approaches in a range of identical simulation scenarios .
14-1	2082-2085	The	abstract[111]	new[111]	_	_
14-2	2086-2097	methodology	abstract[111]	new[111]	_	_
14-3	2098-2100	of	abstract[111]	new[111]	_	_
14-4	2101-2105	this	abstract[111]|abstract[112]	new[111]|new[112]	_	_
14-5	2106-2110	work	abstract[111]|abstract[112]	new[111]|new[112]	_	_
14-6	2111-2113	is	_	_	_	_
14-7	2114-2122	proposed	_	_	_	_
14-8	2123-2125	to	_	_	_	_
14-9	2126-2134	evaluate	_	_	_	_
14-10	2135-2138	the	abstract[113]	new[113]	_	_
14-11	2139-2145	merits	abstract[113]	new[113]	_	_
14-12	2146-2148	of	abstract[113]	new[113]	_	_
14-13	2149-2150	a	abstract[113]|abstract[116]	new[113]|new[116]	coref	15-4[122_116]
14-14	2151-2161	full-state	abstract[113]|abstract[116]	new[113]|new[116]	_	_
14-15	2162-2170	feedback	abstract[113]|abstract|abstract[116]	new[113]|new|new[116]	_	_
14-16	2171-2178	control	abstract[113]|event|abstract[116]	new[113]|giv|new[116]	_	_
14-17	2179-2185	method	abstract[113]|abstract[116]	new[113]|new[116]	_	_
14-18	2186-2195	involving	_	_	_	_
14-19	2196-2206	sensorless	abstract	giv	_	_
14-20	2207-2210	and	_	_	_	_
14-21	2211-2223	non-invasive	_	_	_	_
14-22	2224-2234	approaches	abstract	giv	_	_
14-23	2235-2237	in	_	_	_	_
14-24	2238-2239	a	_	_	_	_
14-25	2240-2245	range	_	_	_	_
14-26	2246-2248	of	_	_	_	_
14-27	2249-2258	identical	event[120]	new[120]	coref	34-15[159_120]
14-28	2259-2269	simulation	abstract|event[120]	new|new[120]	coref	32-3
14-29	2270-2279	scenarios	event[120]	new[120]	_	_
14-30	2280-2281	.	_	_	_	_

#Text=The results of this method show that the controller has advantages in regulating the reference signal generated with the safe mode at a variable speed , as illustrated in
15-1	2282-2285	The	abstract[121]	new[121]	_	_
15-2	2286-2293	results	abstract[121]	new[121]	_	_
15-3	2294-2296	of	abstract[121]	new[121]	_	_
15-4	2297-2301	this	abstract[121]|abstract[122]	new[121]|giv[122]	_	_
15-5	2302-2308	method	abstract[121]|abstract[122]	new[121]|giv[122]	_	_
15-6	2309-2313	show	_	_	_	_
15-7	2314-2318	that	_	_	_	_
15-8	2319-2322	the	object[123]	giv[123]	_	_
15-9	2323-2333	controller	object[123]	giv[123]	_	_
15-10	2334-2337	has	_	_	_	_
15-11	2338-2348	advantages	abstract	new	_	_
15-12	2349-2351	in	_	_	_	_
15-13	2352-2362	regulating	_	_	_	_
15-14	2363-2366	the	abstract[126]	new[126]	_	_
15-15	2367-2376	reference	abstract|abstract[126]	new|new[126]	_	_
15-16	2377-2383	signal	abstract[126]	new[126]	_	_
15-17	2384-2393	generated	_	_	_	_
15-18	2394-2398	with	_	_	_	_
15-19	2399-2402	the	abstract[127]	new[127]	_	_
15-20	2403-2407	safe	abstract[127]	new[127]	_	_
15-21	2408-2412	mode	abstract[127]	new[127]	_	_
15-22	2413-2415	at	abstract[127]	new[127]	_	_
15-23	2416-2417	a	abstract[127]|abstract[128]	new[127]|giv[128]	_	_
15-24	2418-2426	variable	abstract[127]|abstract[128]	new[127]|giv[128]	_	_
15-25	2427-2432	speed	abstract[127]|abstract[128]	new[127]|giv[128]	_	_
15-26	2433-2434	,	_	_	_	_
15-27	2435-2437	as	_	_	_	_
15-28	2438-2449	illustrated	_	_	_	_
15-29	2450-2452	in	_	_	_	_

#Text=Figure 4
16-1	2453-2459	Figure	abstract[129]	new[129]	_	_
16-2	2460-2461	4	abstract[129]	new[129]	_	_

#Text=,
17-1	2462-2463	,	_	_	_	_

#Text=Figure 5
18-1	2464-2470	Figure	abstract[130]	new[130]	_	_
18-2	2471-2472	5	abstract[130]	new[130]	_	_

#Text=,
19-1	2473-2474	,	_	_	_	_

#Text=Figure 6
20-1	2475-2481	Figure	object[131]	new[131]	_	_
20-2	2482-2483	6	object[131]	new[131]	_	_

#Text=,
21-1	2484-2485	,	_	_	_	_

#Text=Figure 7
22-1	2486-2492	Figure	abstract[132]	new[132]	_	_
22-2	2493-2494	7	abstract[132]	new[132]	_	_

#Text=,
23-1	2495-2496	,	_	_	_	_

#Text=Figure 8
24-1	2497-2503	Figure	abstract[133]	new[133]	_	_
24-2	2504-2505	8	abstract[133]	new[133]	_	_

#Text=,
25-1	2506-2507	,	_	_	_	_

#Text=Figure 9
26-1	2508-2514	Figure	abstract[134]	new[134]	_	_
26-2	2515-2516	9	abstract[134]	new[134]	_	_

#Text=,
27-1	2517-2518	,	_	_	_	_

#Text=Figure 10
28-1	2519-2525	Figure	abstract[135]	new[135]	_	_
28-2	2526-2528	10	abstract[135]	new[135]	_	_

#Text=and
29-1	2529-2532	and	_	_	_	_

#Text=Figure 11
30-1	2533-2539	Figure	abstract[136]	new[136]	_	_
30-2	2540-2542	11	abstract[136]	new[136]	_	_

#Text=.
31-1	2543-2544	.	_	_	_	_

#Text=The software simulation model currently simulates rest and exercise with changes in HR , cardiac contractility , and systemic vascular resistance .
32-1	2545-2548	The	abstract[139]	new[139]	coref	34-10[158_139]
32-2	2549-2557	software	object|abstract[139]	new|new[139]	coref	34-11
32-3	2558-2568	simulation	abstract|abstract[139]	giv|new[139]	coref	42-17
32-4	2569-2574	model	abstract[139]	new[139]	_	_
32-5	2575-2584	currently	_	_	_	_
32-6	2585-2594	simulates	_	_	_	_
32-7	2595-2599	rest	event	new	_	_
32-8	2600-2603	and	_	_	_	_
32-9	2604-2612	exercise	event[141]	new[141]	coref	36-14[0_141]
32-10	2613-2617	with	event[141]	new[141]	_	_
32-11	2618-2625	changes	event[141]|abstract[142]	new[141]|new[142]	coref	33-7[147_142]
32-12	2626-2628	in	event[141]|abstract[142]	new[141]|new[142]	_	_
32-13	2629-2631	HR	event[141]|abstract[142]|time	new[141]|new[142]|new	_	_
32-14	2632-2633	,	event[141]|abstract[142]	new[141]|new[142]	_	_
32-15	2634-2641	cardiac	event[141]|abstract[142]|abstract[144]	new[141]|new[142]|giv[144]	_	_
32-16	2642-2655	contractility	event[141]|abstract[142]|abstract[144]	new[141]|new[142]|giv[144]	_	_
32-17	2656-2657	,	event[141]|abstract[142]	new[141]|new[142]	_	_
32-18	2658-2661	and	event[141]|abstract[142]	new[141]|new[142]	_	_
32-19	2662-2670	systemic	event[141]|abstract[142]|abstract[145]	new[141]|new[142]|new[145]	ana	33-3[0_145]
32-20	2671-2679	vascular	event[141]|abstract[142]|abstract[145]	new[141]|new[142]|new[145]	_	_
32-21	2680-2690	resistance	event[141]|abstract[142]|abstract[145]	new[141]|new[142]|new[145]	_	_
32-22	2691-2692	.	_	_	_	_

#Text=Clinically , it is observed that large changes in pump pulsatility during postural changes cause patients to sometimes feel weak during Valsalva maneuvers ( e. g. , when coughing or straining ) .
33-1	2693-2703	Clinically	_	_	_	_
33-2	2704-2705	,	_	_	_	_
33-3	2706-2708	it	abstract	giv	coref	37-11
33-4	2709-2711	is	_	_	_	_
33-5	2712-2720	observed	_	_	_	_
33-6	2721-2725	that	_	_	_	_
33-7	2726-2731	large	abstract[147]	giv[147]	_	_
33-8	2732-2739	changes	abstract[147]	giv[147]	_	_
33-9	2740-2742	in	abstract[147]	giv[147]	_	_
33-10	2743-2747	pump	abstract[147]|object|abstract[149]	giv[147]|new|new[149]	coref|coref	39-17[0_149]|39-17[0_149]
33-11	2748-2759	pulsatility	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
33-12	2760-2766	during	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
33-13	2767-2775	postural	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
33-14	2776-2783	changes	abstract[147]|abstract[149]	giv[147]|new[149]	_	_
33-15	2784-2789	cause	_	_	_	_
33-16	2790-2798	patients	person	new	coref	35-13[163_0]
33-17	2799-2801	to	_	_	_	_
33-18	2802-2811	sometimes	_	_	_	_
33-19	2812-2816	feel	_	_	_	_
33-20	2817-2821	weak	_	_	_	_
33-21	2822-2828	during	_	_	_	_
33-22	2829-2837	Valsalva	person|abstract[152]	new|new[152]	appos|appos	33-25[153_152]|33-25[153_152]
33-23	2838-2847	maneuvers	abstract[152]	new[152]	_	_
33-24	2848-2849	(	_	_	_	_
33-25	2850-2852	e.	abstract[153]	giv[153]	_	_
33-26	2853-2855	g.	abstract[153]	giv[153]	_	_
33-27	2856-2857	,	_	_	_	_
33-28	2858-2862	when	_	_	_	_
33-29	2863-2871	coughing	_	_	_	_
33-30	2872-2874	or	_	_	_	_
33-31	2875-2884	straining	_	_	_	_
33-32	2885-2886	)	_	_	_	_
33-33	2887-2888	.	_	_	_	_

#Text=Therefore , we believe it is important to improve the software model to represent these events .
34-1	2889-2898	Therefore	_	_	_	_
34-2	2899-2900	,	_	_	_	_
34-3	2901-2903	we	person	acc	ana	37-1
34-4	2904-2911	believe	_	_	_	_
34-5	2912-2914	it	abstract	new	cata	34-5[0_156]
34-6	2915-2917	is	_	_	_	_
34-7	2918-2927	important	_	_	_	_
34-8	2928-2930	to	abstract[156]	new[156]	_	_
34-9	2931-2938	improve	abstract[156]	new[156]	_	_
34-10	2939-2942	the	abstract[156]|abstract[158]	new[156]|giv[158]	_	_
34-11	2943-2951	software	abstract[156]|object|abstract[158]	new[156]|giv|giv[158]	_	_
34-12	2952-2957	model	abstract[156]|abstract[158]	new[156]|giv[158]	_	_
34-13	2958-2960	to	_	_	_	_
34-14	2961-2970	represent	_	_	_	_
34-15	2971-2976	these	event[159]	giv[159]	_	_
34-16	2977-2983	events	event[159]	giv[159]	_	_
34-17	2984-2985	.	_	_	_	_

#Text=In addition , the aortic valve is observed to be closed in most LVAD patients .
35-1	2986-2988	In	_	_	_	_
35-2	2989-2997	addition	_	_	_	_
35-3	2998-2999	,	_	_	_	_
35-4	3000-3003	the	object[161]	new[161]	coref	37-5[172_161]
35-5	3004-3010	aortic	abstract|object[161]	new|new[161]	coref	37-6
35-6	3011-3016	valve	object[161]	new[161]	_	_
35-7	3017-3019	is	_	_	_	_
35-8	3020-3028	observed	_	_	_	_
35-9	3029-3031	to	_	_	_	_
35-10	3032-3034	be	_	_	_	_
35-11	3035-3041	closed	_	_	_	_
35-12	3042-3044	in	_	_	_	_
35-13	3045-3049	most	person[163]	giv[163]	_	_
35-14	3050-3054	LVAD	abstract|person[163]	new|giv[163]	coref	37-15
35-15	3055-3063	patients	person[163]	giv[163]	_	_
35-16	3064-3065	.	_	_	_	_

#Text=However , with a change in posture , cardiac recovery , and during exercise , it may open .
36-1	3066-3073	However	_	_	_	_
36-2	3074-3075	,	_	_	_	_
36-3	3076-3080	with	_	_	_	_
36-4	3081-3082	a	event[164]	new[164]	_	_
36-5	3083-3089	change	event[164]	new[164]	_	_
36-6	3090-3092	in	event[164]	new[164]	_	_
36-7	3093-3100	posture	event[164]|abstract	new[164]|new	_	_
36-8	3101-3102	,	event[164]	new[164]	_	_
36-9	3103-3110	cardiac	event[164]|person|event[167]	new[164]|new|new[167]	_	_
36-10	3111-3119	recovery	event[164]|event[167]	new[164]|new[167]	_	_
36-11	3120-3121	,	_	_	_	_
36-12	3122-3125	and	_	_	_	_
36-13	3126-3132	during	_	_	_	_
36-14	3133-3141	exercise	event	giv	ana	36-16
36-15	3142-3143	,	_	_	_	_
36-16	3144-3146	it	event	giv	_	_
36-17	3147-3150	may	_	_	_	_
36-18	3151-3155	open	_	_	_	_
36-19	3156-3157	.	_	_	_	_

#Text=We have found that the aortic valve offers a lower resistance pathway than the LVAD bypass route , as the native heart sometimes pumps a significant flow relative to that of the LVAD .
37-1	3158-3160	We	person	giv	ana	38-3
37-2	3161-3165	have	_	_	_	_
37-3	3166-3171	found	_	_	_	_
37-4	3172-3176	that	_	_	_	_
37-5	3177-3180	the	object[172]	giv[172]	_	_
37-6	3181-3187	aortic	abstract|object[172]	giv|giv[172]	_	_
37-7	3188-3193	valve	object[172]	giv[172]	_	_
37-8	3194-3200	offers	_	_	_	_
37-9	3201-3202	a	place[174]	new[174]	ana	37-30[180_174]
37-10	3203-3208	lower	place[174]	new[174]	_	_
37-11	3209-3219	resistance	abstract|place[174]	giv|new[174]	_	_
37-12	3220-3227	pathway	place[174]	new[174]	_	_
37-13	3228-3232	than	place[174]	new[174]	_	_
37-14	3233-3236	the	place[174]|abstract[177]	new[174]|new[177]	_	_
37-15	3237-3241	LVAD	place[174]|abstract|abstract[177]	new[174]|giv|new[177]	coref	37-32[181_0]
37-16	3242-3248	bypass	place[174]|object|abstract[177]	new[174]|new|new[177]	_	_
37-17	3249-3254	route	place[174]|abstract[177]	new[174]|new[177]	_	_
37-18	3255-3256	,	_	_	_	_
37-19	3257-3259	as	_	_	_	_
37-20	3260-3263	the	abstract[178]	new[178]	coref	41-15[0_178]
37-21	3264-3270	native	abstract[178]	new[178]	_	_
37-22	3271-3276	heart	abstract[178]	new[178]	_	_
37-23	3277-3286	sometimes	_	_	_	_
37-24	3287-3292	pumps	_	_	_	_
37-25	3293-3294	a	abstract[179]	new[179]	_	_
37-26	3295-3306	significant	abstract[179]	new[179]	_	_
37-27	3307-3311	flow	abstract[179]	new[179]	_	_
37-28	3312-3320	relative	abstract[179]	new[179]	_	_
37-29	3321-3323	to	_	_	_	_
37-30	3324-3328	that	place[180]	giv[180]	_	_
37-31	3329-3331	of	place[180]	giv[180]	_	_
37-32	3332-3335	the	place[180]|abstract[181]	giv[180]|giv[181]	coref	43-18[0_181]
37-33	3336-3340	LVAD	place[180]|abstract[181]	giv[180]|giv[181]	_	_
37-34	3341-3342	.	_	_	_	_

#Text=Therefore , we believe that this different pumping state could greatly impact our overall control strategy , and therefore requires online detection .
38-1	3343-3352	Therefore	_	_	_	_
38-2	3353-3354	,	_	_	_	_
38-3	3355-3357	we	person	giv	ana	38-13
38-4	3358-3365	believe	_	_	_	_
38-5	3366-3370	that	_	_	_	_
38-6	3371-3375	this	abstract[184]	new[184]	_	_
38-7	3376-3385	different	abstract[184]	new[184]	_	_
38-8	3386-3393	pumping	abstract|abstract[184]	new|new[184]	_	_
38-9	3394-3399	state	abstract[184]	new[184]	_	_
38-10	3400-3405	could	_	_	_	_
38-11	3406-3413	greatly	_	_	_	_
38-12	3414-3420	impact	_	_	_	_
38-13	3421-3424	our	person|abstract[187]	giv|new[187]	ana|ana	42-6|42-6
38-14	3425-3432	overall	abstract[187]	new[187]	_	_
38-15	3433-3440	control	abstract|abstract[187]	new|new[187]	_	_
38-16	3441-3449	strategy	abstract[187]	new[187]	_	_
38-17	3450-3451	,	_	_	_	_
38-18	3452-3455	and	_	_	_	_
38-19	3456-3465	therefore	_	_	_	_
38-20	3466-3474	requires	_	_	_	_
38-21	3475-3481	online	abstract[188]	new[188]	_	_
38-22	3482-3491	detection	abstract[188]	new[188]	_	_
38-23	3492-3493	.	_	_	_	_

#Text=In addition , during use in a clinical setting , it was found that controlling the pulsatility index to a pre-set point did not prevent antagonistic pumping states .
39-1	3494-3496	In	_	_	_	_
39-2	3497-3505	addition	_	_	_	_
39-3	3506-3507	,	_	_	_	_
39-4	3508-3514	during	_	_	_	_
39-5	3515-3518	use	abstract[189]	new[189]	_	_
39-6	3519-3521	in	abstract[189]	new[189]	_	_
39-7	3522-3523	a	abstract[189]|abstract[190]	new[189]|new[190]	ana	39-11[0_190]
39-8	3524-3532	clinical	abstract[189]|abstract[190]	new[189]|new[190]	_	_
39-9	3533-3540	setting	abstract[189]|abstract[190]	new[189]|new[190]	_	_
39-10	3541-3542	,	_	_	_	_
39-11	3543-3545	it	abstract	giv	_	_
39-12	3546-3549	was	_	_	_	_
39-13	3550-3555	found	_	_	_	_
39-14	3556-3560	that	_	_	_	_
39-15	3561-3572	controlling	_	_	_	_
39-16	3573-3576	the	abstract[193]	new[193]	coref	41-5[202_193]
39-17	3577-3588	pulsatility	abstract|abstract[193]	giv|new[193]	coref	41-6
39-18	3589-3594	index	abstract[193]	new[193]	_	_
39-19	3595-3597	to	_	_	_	_
39-20	3598-3599	a	abstract[194]	new[194]	_	_
39-21	3600-3607	pre-set	abstract[194]	new[194]	_	_
39-22	3608-3613	point	abstract[194]	new[194]	_	_
39-23	3614-3617	did	_	_	_	_
39-24	3618-3621	not	_	_	_	_
39-25	3622-3629	prevent	_	_	_	_
39-26	3630-3642	antagonistic	abstract[195]	new[195]	_	_
39-27	3643-3650	pumping	abstract[195]	new[195]	_	_
39-28	3651-3657	states	abstract[195]	new[195]	_	_
39-29	3658-3659	.	_	_	_	_

#Text=On the contrary , occasional suction occurred , which led to the development of algorithms for anti-suction .
40-1	3660-3662	On	_	_	_	_
40-2	3663-3666	the	_	_	_	_
40-3	3667-3675	contrary	_	_	_	_
40-4	3676-3677	,	_	_	_	_
40-5	3678-3688	occasional	abstract[196]	new[196]	_	_
40-6	3689-3696	suction	abstract[196]	new[196]	_	_
40-7	3697-3705	occurred	_	_	_	_
40-8	3706-3707	,	_	_	_	_
40-9	3708-3713	which	_	_	_	_
40-10	3714-3717	led	_	_	_	_
40-11	3718-3720	to	_	_	_	_
40-12	3721-3724	the	abstract[197]	new[197]	_	_
40-13	3725-3736	development	abstract[197]	new[197]	_	_
40-14	3737-3739	of	abstract[197]	new[197]	_	_
40-15	3740-3750	algorithms	abstract[197]|abstract[198]	new[197]|new[198]	_	_
40-16	3751-3754	for	abstract[197]|abstract[198]	new[197]|new[198]	_	_
40-17	3755-3767	anti-suction	abstract[197]|abstract[198]|abstract	new[197]|new[198]|new	_	_
40-18	3768-3769	.	_	_	_	_

#Text=Another drawback is that the pulsatility index ( PI ) is increasingly dependent on heart rate .
41-1	3770-3777	Another	abstract[200]	new[200]	_	_
41-2	3778-3786	drawback	abstract[200]	new[200]	_	_
41-3	3787-3789	is	_	_	_	_
41-4	3790-3794	that	_	_	_	_
41-5	3795-3798	the	abstract[202]	giv[202]	_	_
41-6	3799-3810	pulsatility	abstract|abstract[202]	giv|giv[202]	_	_
41-7	3811-3816	index	abstract[202]	giv[202]	_	_
41-8	3817-3818	(	_	_	_	_
41-9	3819-3821	PI	abstract	giv	_	_
41-10	3822-3823	)	_	_	_	_
41-11	3824-3826	is	_	_	_	_
41-12	3827-3839	increasingly	_	_	_	_
41-13	3840-3849	dependent	_	_	_	_
41-14	3850-3852	on	_	_	_	_
41-15	3853-3858	heart	abstract|abstract[205]	giv|new[205]	ana|ana	43-1[0_205]|43-1[0_205]
41-16	3859-3863	rate	abstract[205]	new[205]	_	_
41-17	3864-3865	.	_	_	_	_

#Text=For real-time clinical studies , we plan to validate the controller built in the above-mentioned computer simulation studies in a pulsatile mock circulation loop .
42-1	3866-3869	For	_	_	_	_
42-2	3870-3879	real-time	event[206]	new[206]	coref	42-14[211_206]
42-3	3880-3888	clinical	event[206]	new[206]	_	_
42-4	3889-3896	studies	event[206]	new[206]	_	_
42-5	3897-3898	,	_	_	_	_
42-6	3899-3901	we	person	giv	_	_
42-7	3902-3906	plan	_	_	_	_
42-8	3907-3909	to	_	_	_	_
42-9	3910-3918	validate	_	_	_	_
42-10	3919-3922	the	object[208]	new[208]	coref	43-17[223_208]
42-11	3923-3933	controller	object[208]	new[208]	_	_
42-12	3934-3939	built	_	_	_	_
42-13	3940-3942	in	_	_	_	_
42-14	3943-3946	the	event[211]	giv[211]	coref	44-9[227_211]
42-15	3947-3962	above-mentioned	event[211]	giv[211]	_	_
42-16	3963-3971	computer	object|event[211]	new|giv[211]	coref	44-2
42-17	3972-3982	simulation	abstract|event[211]	giv|giv[211]	_	_
42-18	3983-3990	studies	event[211]	giv[211]	_	_
42-19	3991-3993	in	event[211]	giv[211]	_	_
42-20	3994-3995	a	event[211]|object[214]	giv[211]|new[214]	_	_
42-21	3996-4005	pulsatile	event[211]|object[214]	giv[211]|new[214]	_	_
42-22	4006-4010	mock	event[211]|place|object[214]	giv[211]|new|new[214]	_	_
42-23	4011-4022	circulation	event[211]|abstract|object[214]	giv[211]|new|new[214]	_	_
42-24	4023-4027	loop	event[211]|object[214]	giv[211]|new[214]	_	_
42-25	4028-4029	.	_	_	_	_

#Text=This will include the design of a LabView/MATLAB system for the implementation of control strategies in the LVAD physical controller .
43-1	4030-4034	This	abstract	giv	_	_
43-2	4035-4039	will	_	_	_	_
43-3	4040-4047	include	_	_	_	_
43-4	4048-4051	the	abstract[216]	new[216]	_	_
43-5	4052-4058	design	abstract[216]	new[216]	_	_
43-6	4059-4061	of	abstract[216]	new[216]	_	_
43-7	4062-4063	a	abstract[216]|object[218]	new[216]|new[218]	coref	44-1[225_218]
43-8	4064-4078	LabView/MATLAB	abstract[216]|organization|object[218]	new[216]|new|new[218]	_	_
43-9	4079-4085	system	abstract[216]|object[218]	new[216]|new[218]	_	_
43-10	4086-4089	for	abstract[216]	new[216]	_	_
43-11	4090-4093	the	abstract[216]|abstract[219]	new[216]|new[219]	_	_
43-12	4094-4108	implementation	abstract[216]|abstract[219]	new[216]|new[219]	_	_
43-13	4109-4111	of	abstract[216]|abstract[219]	new[216]|new[219]	_	_
43-14	4112-4119	control	abstract[216]|abstract[219]|person|abstract[221]	new[216]|new[219]|new|new[221]	_	_
43-15	4120-4130	strategies	abstract[216]|abstract[219]|abstract[221]	new[216]|new[219]|new[221]	_	_
43-16	4131-4133	in	abstract[216]|abstract[219]|abstract[221]	new[216]|new[219]|new[221]	_	_
43-17	4134-4137	the	abstract[216]|abstract[219]|abstract[221]|object[223]	new[216]|new[219]|new[221]|giv[223]	_	_
43-18	4138-4142	LVAD	abstract[216]|abstract[219]|abstract[221]|abstract|object[223]	new[216]|new[219]|new[221]|giv|giv[223]	_	_
43-19	4143-4151	physical	abstract[216]|abstract[219]|abstract[221]|object[223]	new[216]|new[219]|new[221]|giv[223]	_	_
43-20	4152-4162	controller	abstract[216]|abstract[219]|abstract[221]|object[223]	new[216]|new[219]|new[221]|giv[223]	_	_
43-21	4163-4164	.	_	_	_	_

#Text=This computer system will then be used in acute animal studies .
44-1	4165-4169	This	object[225]	giv[225]	_	_
44-2	4170-4178	computer	object|object[225]	giv|giv[225]	_	_
44-3	4179-4185	system	object[225]	giv[225]	_	_
44-4	4186-4190	will	_	_	_	_
44-5	4191-4195	then	_	_	_	_
44-6	4196-4198	be	_	_	_	_
44-7	4199-4203	used	_	_	_	_
44-8	4204-4206	in	_	_	_	_
44-9	4207-4212	acute	event[227]	giv[227]	_	_
44-10	4213-4219	animal	animal|event[227]	new|giv[227]	_	_
44-11	4220-4227	studies	event[227]	giv[227]	_	_
44-12	4228-4229	.	_	_	_	_
